China Universal Asset Management Co. Ltd. Has $1.76 Million Holdings in CVS Health Corporation $CVS

China Universal Asset Management Co. Ltd. cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 22.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,300 shares of the pharmacy operator’s stock after selling 6,700 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in CVS Health were worth $1,757,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CVS. Avion Wealth raised its holdings in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC acquired a new position in CVS Health in the third quarter valued at about $29,000. Front Row Advisors LLC lifted its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the period. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in CVS Health during the second quarter worth about $36,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 0.9%

Shares of NYSE:CVS opened at $76.64 on Friday. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15. The company has a market capitalization of $97.50 billion, a PE ratio of 55.53, a price-to-earnings-growth ratio of 0.81 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The company has a fifty day moving average of $78.52 and a 200-day moving average of $76.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is presently 192.75%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Wells Fargo & Company lowered their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Morgan Stanley raised their target price on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Robert W. Baird boosted their price target on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Finally, TD Cowen upped their price objective on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.